Diabetes insipidus
00:00 / 00:00
Videos
Notes
Diabetes insipidus
Endocrine system
Polyglandular syndromes
Autoimmune polyglandular syndrome type 1 (NORD)
Endocrine system pathology review
Adrenal insufficiency: Pathology review
Adrenal masses: Pathology review
Cushing syndrome and Cushing disease: Pathology review
Diabetes insipidus and SIADH: Pathology review
Diabetes mellitus: Pathology review
Hyperthyroidism: Pathology review
Hypopituitarism: Pathology review
Hypothyroidism: Pathology review
Multiple endocrine neoplasia: Pathology review
Neuroendocrine tumors of the gastrointestinal system: Pathology review
Parathyroid disorders and calcium imbalance: Pathology review
Pituitary tumors: Pathology review
Thyroid nodules and thyroid cancer: Pathology review
Assessments
Diabetes insipidus
Flashcards
0 / 6 complete
USMLE® Step 1 questions
0 / 2 complete
High Yield Notes
13 pages
Flashcards
Diabetes insipidus
of complete
Questions
USMLE® Step 1 style questions USMLE
of complete
| Laboratory value | Result |
| Sodium | 150 mEq/L |
| Serum osmolality | 309 mOsmol/kg |
| Urine osmolality | 187 mOsmol/kg |
There is inadequate change in the values after two hours of water deprivation. Desmopressin (antidiuretic hormone analog) is then administered. Laboratory studies one hour later revealed serum osmolality of 282 mOsmol/kg and urine osmolality of 500 mOsmol/kg. Which of the following is the most likely diagnosis?
External References
First Aid
2022
2021
2020
2019
2018
2017
2016
Amiloride p. 633
for diabetes insipidus p. 351
Antidiuretic hormone (ADH) p. 340, 612
in diabetes insipidus p. 344
Demeclocycline p. 362
diabetes insipidus and p. 250, 351
Diabetes insipidus p. 351
antidiuretic hormone in p. 340
demeclocycline and p. 364
desmopressin acetate for p. 364
drug reaction and p. 250
lithium p. 598
lithium toxicity p. 593
potassium-sparing diuretics for p. 633
thiazides for p. 633
Hydrochlorothiazide (HCTZ) p. 633
for diabetes insipidus p. 344
Hypercalcemia p. 615
diabetes insipidus p. 351
Indomethacin p. 499
for diabetes insipidus p. 351
Lithium p. 598
diabetes insipidus and p. 250, 351
Nephrogenic, diabetes insipidus
Pituitary tumors
diabetes insipidus p. 344
Polyuria p. 624
diabetes insipidus p. 351
Transcript
Content Reviewers
With diabetes insipidus, “diabetes” means an increased passing of urine, and “insipidus” means tasteless; so diabetes insipidus is a condition characterized by the production of large quantities of dilute and tasteless urine.
The tasteless urine of diabetes insipidus distinguishes it from diabetes mellitus which describes sweet tasting urine- and, yes, urine was really tasted at one point in time to make that distinction!
Now, in the brain there’s a region called the hypothalamus.
Inside the hypothalamus are osmoreceptors, which can sense the osmolality of the blood, or how concentrated it is.
Osmolality is the concentration of dissolved particles in the blood plasma, or the liquid portion of blood.
There are a number of dissolved particles in the blood plasma, but the major ones are glucose, sodium, and blood urea nitrogen, and a normal osmolality is between 285 and 295 milli Osmoles per kilogram.
During periods of dehydration there is an increase in concentration of these particles in the blood and osmolality increases.
The osmoreceptors in the hypothalamus detect the increased osmolality and that triggers the sensation of thirst, which tells us to drink more water. The water then gets absorbed and dilutes the blood, bringing the osmolality back to normal.
In addition to osmoreceptors, the hypothalamus also contains a cluster of neurons that are found in a specific spot called the supraoptic nucleus.
These neurons produce a hormone called antidiuretic hormone, or ADH. ADH is also called vasopressin because it causes smooth muscle around the blood vessels to contract, which increases blood resistance and raises blood pressure.
When the osmoreceptors detect high osmolality, they signal the supraoptic nucleus to send ADH down the supraoptico-hypophyseal tract, which runs through the infundibulum or pituitary stalk, and into the posterior pituitary gland, where it is then released into the blood.
Summary
Diabetes insipidus is when the body cannot regulate its fluid levels properly and loses a lot of water in the urine. There are two major types of diabetes insipidus, which are central and nephrogenic diabetes insipidus. Central diabetes insipidus occurs when the hypothalamus is not producing enough antidiuretic hormone (ADH). ADH ensures that the kidneys produce less urine and reduce water loss. On the other hand, nephrogenic diabetes insipidus results from the kidneys failing to respond to ADH. People with diabetes insipidus present with excessive quantities of diluted urine (polyuria), resulting in excessive thirst (polydipsia).
Sources
- "Robbins Basic Pathology" Elsevier (2017)
- "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
- "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
- "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
- "Harrison's Endocrinology, 4E" McGraw-Hill Education / Medical (2016)
- "THE PATHOGENESIS OF DIABETES INSIPIDUS." Journal of the American Medical Association (1907)
- "Management of Hypopituitarism" Journal of Clinical Medicine (2019)
- "Post-Traumatic Hypopituitarism—Who Should Be Screened, When, and How?" Frontiers in Endocrinology (2018)
For Institutions
Copyright © 2023 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.
